Partial fatty acid oxidation inhibitors for stable angina

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.5, 2002-05, pp. : 615-629

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat

By Zacharowski K. Blackburn B. Thiemermann C.

European Journal of Pharmacology, Vol. 418, Iss. 1, 2001-04 ,pp. : 105-110

Elsevier

Access to resources Recommend Favorite

Trimetazidine for stable angina pectoris

By Cross H.R.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 857-875

Informa Healthcare

Access to resources Recommend Favorite

Hepatic Steatosis and Peroxisomal Fatty Acid Beta-oxidation

Current Drug Metabolism, Vol. 13, Iss. 10, 2012-01 ,pp. : 1412-1421

Bentham Science Publishers

Access to resources Recommend Favorite

Fatty Acid Amide Hydrolase Inhibitors - Progress and Potential

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 545-558

Bentham Science Publishers

Access to resources Recommend Favorite

Fatty acid synthase inhibitors: new directions for oncology

By Kridel Steven J Lowther W Todd Pemble IV Charles W

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 11, 2007-11 ,pp. : 1817-1829

Informa Healthcare

Access to resources Recommend Favorite